MARKET

SNGX

SNGX

Soligenix Inc
NASDAQ
0.4000
-0.0100
-2.44%
After Hours: 0.3970 -0.003 -0.75% 19:56 06/29 EDT
OPEN
0.4100
PREV CLOSE
0.4100
HIGH
0.4101
LOW
0.3950
VOLUME
449.54K
TURNOVER
--
52 WEEK HIGH
6.23
52 WEEK LOW
0.2800
MARKET CAP
5.93M
P/E (TTM)
-0.2027
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SNGX last week (0622-0626)?
Weekly Report · 21h ago
Soligenix Expands At-the-Market Equity Offering Capacity
TipRanks · 3d ago
Soligenix increases at-the-market offering by additional $2.5 million
PUBT · 3d ago
SOLIGENIX INC - FILES FOR OFFERING OF UP TO $2.5 MLN COMMON STOCK - SEC FILING
Reuters · 3d ago
Weekly Report: what happened at SNGX last week (0615-0619)?
Weekly Report · 06/22 09:15
Weekly Report: what happened at SNGX last week (0608-0612)?
Weekly Report · 06/15 09:14
Soligenix Halts HyBryte Program, Refocuses Pipeline Strategy
TipRanks · 06/12 21:05
Soligenix names Christopher Pullion to assume CMO duties after Straube exits consulting role
PUBT · 06/12 20:07
More
About SNGX
Soligenix, Inc. is a late-stage biopharmaceutical company, which is focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).

Webull offers Soligenix Inc stock information, including NASDAQ: SNGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNGX stock methods without spending real money on the virtual paper trading platform.